Study suggests microdroplets from talking may spread virus

Study suggests microdroplets from talking may spread virus
Howard Larkin
Howard Larkin
Published: Friday, April 10, 2020
A study by Kazahiro Tateda MD, PhD, professor of microbiology and infectious disease at Toho University, Tokyo, and NHK, Japan’s national broadcasting organisation, suggests that viruses, including the COVID-19 coronavirus, may be spread by microdroplets released in conversation. With microdroplets remaining airborne for 20 minutes or more in stagnant air, maintaining social distance, wearing masks and occasionally opening the window may help mitigate the infection risk they present. The study used high-speed cameras to examine droplets dispersed when people sneezed, coughed, spoke and breathed. It showed that large droplets expelled by coughing and sneezing settled to the ground rapidly, suggesting they are a temporary inhalation threat. Touching such drops, which measure up to 1.0mm in diameter, after they settle, and then touching the face is thought to be their most common route transmitting disease. However, microdroplets dispersed by talking loudly or breathing heavily not only remained suspended for minutes or hours in the air. They also tended to accumulate in enclosed spaces with poor ventilation. Measuring just a few microns, such microdroplets are still capable of carrying and possibly spreading viruses by inhalation. Creating a cross draft by opening two windows appeared highly effective in clearing the air of suspended microdroplets, said Dr Tateda, who is president of the Japanese Association for Infectious Disease, which partnered in the study. He recommended opening windows periodically to keep microdroplets from accumulating. The study has not been published in a peer reviewed journal, but a report on it has been broadcast on NHK World, and can be viewed here.          
Tags: covid-19 research
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...